Project Grant R41GM157863
Award Date
7/1/25
Completion Date
6/30/26
Dollars Obligated
$299K
Federal Agency
National Institute of General Medical Sciences
Awardee
Epigenter, LLC (LJBRZRERP2G8)
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Providence, RI 02909, USA
Similar Awards
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), totaling $1,207,500.00, supports Duke University's research to develop programmable, isoform-selective proteome editing systems. The project aims to expand upon the university's existing work on peptide-guided enzymes for post-translational protein modifications, enabling both protein degradation and stabilization. Key...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $1,127,364 to The Regents of the University of California, doing business as the University of California, Berkeley (UC Berkeley), for a project period from July 1, 2024 to May 31, 2029. The project aims to unlock the mechanisms of epigenetic memory in human cells, with a focus on understanding how DNA methylation is...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $294,647 to the University of Texas at Dallas (UTD) to develop a theoretical, computational, and experimental framework to model epigenetic regulatory networks in human cells. The key objectives are to: 1) establish a methodology to rapidly assemble and stably integrate libraries of CRISPR-based epigenetic regulators...
This $1,737,000 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the development of innovative single-cell genomics technologies for joint analysis of regulatory dynamics and transcriptional states. Key objectives include: Developing multiomics tools to measure rates of epigenomic changes (DNA methylation, demethylation, oxidative damage, DNA repair) and relate these to...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $2,720,800 in funding to Brigham & Women's Hospital Inc. to conduct research on the epigenetic regulation of transcriptional programming. The research will focus on understanding the dynamic competition between Polycomb (PcG) and Trithorax Group (TrxG) proteins, and how this impacts cell type-specific...
This $1,203,750 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to identify the mechanisms that regulate and coordinate gene expression of DNA methylation "writer" and "eraser" enzymes to maintain epigenetic homeostasis in the model organism Arabidopsis. The primary objectives are to: Perform a mechanistic dissection of the cell-cycle regulation of genes...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports the development of engineered enzymes that can be activated to perform targeted modifications of cellular proteins. The $1,602,000 award to the Dana-Farber Cancer Institute, Inc. (DFCI) will fund research to design and apply novel autoinhibited enzymes that can toggle between inactive and active conformations in response...
The National Institute of General Medical Sciences (NIGMS) awarded a $350,000 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Electronic Biosciences, Inc., a small biotechnology company in San Diego, California. The purpose of this grant is to develop and demonstrate a novel enzyme-based, single-molecule protein sequencing system. This innovative platform will leverage enzymatic processing and advanced bioinformatics to accurately sequence peptides with...
This $325,000 project grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) will support the development and testing of a new class of programmable, non-viral gene therapy carriers and cargo known as virus-inspired DNA origami (VIDO) vectors and repair templates. The project aims to demonstrate that VIDO vectors can effectively encapsulate and co-deliver CRISPR-Cas9 gene editing agents and repair...
This $1,539,200 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) supports the development of an integrated technology platform to characterize the conformational flexibility, heterogeneity, and dynamics of functional oligonucleotides. The key products to be delivered include: A novel ionization technique called Capillary Vibrating Sharp-Edge Spray Ionization (CVSSI) that...